Today: 9 June 2026
Macquarie share price dips as inflation heats up — what MQG investors watch next
29 January 2026
1 min read

Macquarie share price dips as inflation heats up — what MQG investors watch next

Sydney, Jan 29, 2026, 17:36 AEDT — The market has closed.

  • Australia’s inflation spike has refocused attention on the RBA’s Feb. 3 rate decision.
  • Qube pushed back exclusivity, giving Macquarie Asset Management until Feb. 15 to complete due diligence.
  • Macquarie has its next investor update set for a Feb. 10 operational briefing.

Shares of Macquarie Group Ltd slipped 0.33%, closing at A$212.14 on Thursday. The stock fluctuated between A$211.31 and A$214.24 during the session.

The modest shift comes at a tricky time for rate-sensitive financial stocks. Inflation has picked up once more, pushing the market to reconsider a near-term rate hike by the Reserve Bank of Australia.

Macquarie’s earnings are sensitive to shifts in funding costs, market swings, and deal flow — factors that usually intensify as investors revisit their interest rate forecasts.

Consumer prices jumped 3.8% in the year to December 2025, up from 3.4% in the 12 months to November, the Australian Bureau of Statistics reported. The “trimmed mean” inflation rate, which excludes the largest price swings, hit 3.3% annually. Electricity costs soared 21.5%, while inflation on services accelerated to 4.1%. Australian Bureau of Statistics

Westpac economists Justin Smirk and Neha Sharma reported that quarterly trimmed-mean inflation climbed 0.9%, signaling a likely rate hike from the RBA in February. They noted a stronger underlying trend, despite some mixed signals in the monthly data.

The RBA’s cash rate target stands at 3.60%, with the next decision expected at 2:30 p.m. AEDT on Feb. 3 following the board meeting on Feb. 2–3, according to the central bank’s website. This rate represents the overnight cost of unsecured bank loans, and shifts here tend to ripple swiftly through wider lending rates.

Australian shares barely moved as the S&P/ASX 200 index closed down 0.07%.

Macquarie went silent on ASX announcements Thursday, according to ASX data, leaving its shares to follow broader macro and sector trends heading into the close.

Macquarie filed a Form 605 late Wednesday, confirming it was no longer a substantial holder in Sandfire Resources. The notice, signed by the group’s assistant company secretary, is dated Jan. 28.

Qube Holdings announced it has extended exclusivity with Macquarie Asset Management until Feb. 15, allowing due diligence to proceed on a non-binding indicative offer. The proposed price remains steady at A$5.20 per share.

Macquarie plans an operational briefing on Feb. 10 and has set its full-year results release for May 8.

Yet, the immediate risk remains tied to the near-term rate trade. If inflation data softens or the RBA signals a pause, the tightening momentum could reverse sharply. On the other hand, any faltering in the Qube deal process would likely relegate M&A talk to mere speculation.

Next on the calendar: the RBA decision statement arrives Feb. 3, followed by Macquarie’s operational briefing on Feb. 10. Then comes the exclusivity deadline for Qube’s talks with Macquarie Asset Management on Feb. 15.

Stock Market Today

  • Designer Brands (DBI) Beats Q1 Earnings and Revenue Estimates
    June 9, 2026, 10:04 AM EDT. Designer Brands (DBI) reported Q1 earnings of $0.07 per share, surpassing the Zacks estimate of $0.02 and reversing a year-ago loss of $0.26. Revenue hit $696.35 million, just above the $696 million consensus. The company delivered a 250% earnings surprise and has beaten EPS estimates in four consecutive quarters. Shares rose about 19.5% year-to-date, outpacing the S&P 500's 8.2% gain. Despite strong results, the stock holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market. The Retail - Apparel and Shoes sector ranks among the top three industries. Future stock performance will depend on management's outlook and upcoming earnings estimate revisions, with current consensus estimates at $0.30 EPS on $744 million revenue next quarter and $0.35 EPS on $2.91 billion revenue for the fiscal year.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AMD stock price: After-hours uptick as AI-chip rally rolls on ahead of Feb. 3 earnings
Previous Story

AMD stock price: After-hours uptick as AI-chip rally rolls on ahead of Feb. 3 earnings

Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus
Next Story

Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus

Go toTop